As of 2024-12-12, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -26.27. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 3,837.33 mil USD. Novocure's TTM EBITDA according to its financial statements is -146.06 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 35.2x | 20.6x |
| Forward P/E multiples | 18.7x - 39.8x | 28.9x |
| Fair Price | (29.55) - (51.80) | (37.74) |
| Upside | -194.9% - -266.4% | -221.2% |
| Date | EV/EBITDA |
| 2024-11-25 | -16.99 |
| 2024-11-22 | -16.35 |
| 2024-11-21 | -15.87 |
| 2024-11-20 | -15.70 |
| 2024-11-19 | -15.42 |
| 2024-11-18 | -14.86 |
| 2024-11-15 | -15.15 |
| 2024-11-14 | -15.49 |
| 2024-11-13 | -16.46 |
| 2024-11-12 | -16.41 |
| 2024-11-11 | -16.69 |
| 2024-11-08 | -16.13 |
| 2024-11-07 | -16.29 |
| 2024-11-06 | -16.62 |
| 2024-11-05 | -15.52 |
| 2024-11-04 | -15.50 |
| 2024-11-01 | -15.20 |
| 2024-10-31 | -14.46 |
| 2024-10-30 | -15.80 |
| 2024-10-29 | -15.72 |
| 2024-10-28 | -15.52 |
| 2024-10-25 | -15.61 |
| 2024-10-24 | -15.34 |
| 2024-10-23 | -15.20 |
| 2024-10-22 | -15.18 |
| 2024-10-21 | -15.26 |
| 2024-10-18 | -15.96 |
| 2024-10-17 | -15.73 |
| 2024-10-16 | -16.45 |
| 2024-10-15 | -16.38 |
| 2024-10-14 | -15.11 |
| 2024-10-11 | -14.88 |
| 2024-10-10 | -14.23 |
| 2024-10-09 | -14.07 |
| 2024-10-08 | -14.07 |
| 2024-10-07 | -14.03 |
| 2024-10-04 | -14.12 |
| 2024-10-03 | -13.98 |
| 2024-10-02 | -14.69 |
| 2024-10-01 | -14.24 |
| 2024-09-30 | -14.79 |
| 2024-09-27 | -14.78 |
| 2024-09-26 | -14.81 |
| 2024-09-25 | -15.03 |
| 2024-09-24 | -15.38 |
| 2024-09-23 | -15.46 |
| 2024-09-20 | -16.14 |
| 2024-09-19 | -16.43 |
| 2024-09-18 | -16.26 |
| 2024-09-17 | -16.56 |